Literature DB >> 21980015

Design and conduct of intervention-based research among cancer survivors.

Kathleen Y Wolin1, Graham A Colditz.   

Abstract

Intervention trials in cancer survivors play an important and growing role in complementing the wealth of knowledge obtained from observational studies about how lifestyle can improve clinical, physiologic, and psychological outcomes. As the number of intervention trials grows, attention to study design and reporting is essential to establishing a high-quality data pool from which to make evidence-based recommendations and guidelines. We highlight several key issues important to the design and interpretation of intervention trials in cancer survivors. Intervention dose and duration both matter in trials of cancer survivors, yet few trials have evaluated different intervention doses and few intervention trials with multiyear follow-up exist. Finally, there is a need for interventions both of longer duration and those that take a practical trials approach and reflect clinical practice to speed implementation within practice and improve outcomes for cancer survivors. ©2011 AACR

Entities:  

Mesh:

Year:  2011        PMID: 21980015      PMCID: PMC3351000          DOI: 10.1158/1055-9965.EPI-11-0605

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  43 in total

1.  Randomized, controlled trials, observational studies, and the hierarchy of research designs.

Authors:  J Concato; N Shah; R I Horwitz
Journal:  N Engl J Med       Date:  2000-06-22       Impact factor: 91.245

Review 2.  Updated evidence in support of diet and exercise interventions in cancer survivors.

Authors:  Dorothy W Pekmezi; Wendy Demark-Wahnefried
Journal:  Acta Oncol       Date:  2010-11-24       Impact factor: 4.089

3.  Physical activity, weight control, and breast cancer risk and survival: clinical trial rationale and design considerations.

Authors:  Rachel Ballard-Barbash; Sally Hunsberger; Marianne H Alciati; Steven N Blair; Pamela J Goodwin; Anne McTiernan; Rena Wing; Arthur Schatzkin
Journal:  J Natl Cancer Inst       Date:  2009-04-28       Impact factor: 13.506

4.  Folate and cardiovascular disease: one size does not fit all.

Authors:  Eric B Rimm; Meir J Stampfer
Journal:  Lancet       Date:  2011-07-29       Impact factor: 79.321

Review 5.  Efficacy of exercise interventions in modulating cancer-related fatigue among adult cancer survivors: a meta-analysis.

Authors:  Justin C Brown; Tania B Huedo-Medina; Linda S Pescatello; Shannon M Pescatello; Rebecca A Ferrer; Blair T Johnson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-11-04       Impact factor: 4.254

Review 6.  Physical activity motivation and cancer survivorship.

Authors:  Bernardine M Pinto; Joseph T Ciccolo
Journal:  Recent Results Cancer Res       Date:  2011

7.  Long-term survival after radical prostatectomy versus external-beam radiotherapy for patients with high-risk prostate cancer.

Authors:  Stephen A Boorjian; R Jeffrey Karnes; Rosalia Viterbo; Laureano J Rangel; Eric J Bergstralh; Eric M Horwitz; Michael L Blute; Mark K Buyyounouski
Journal:  Cancer       Date:  2011-01-10       Impact factor: 6.860

8.  Bias in treatment assignment in controlled clinical trials.

Authors:  T C Chalmers; P Celano; H S Sacks; H Smith
Journal:  N Engl J Med       Date:  1983-12-01       Impact factor: 91.245

Review 9.  Prevention trials: their place in how we understand the value of prevention strategies.

Authors:  Graham A Colditz; Philip R Taylor
Journal:  Annu Rev Public Health       Date:  2010       Impact factor: 21.981

10.  Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort study.

Authors:  Jennifer L Patnaik; Tim Byers; Carolyn DiGuiseppi; Dana Dabelea; Thomas D Denberg
Journal:  Breast Cancer Res       Date:  2011-06-20       Impact factor: 6.466

View more
  1 in total

1.  Telephone-delivered nutrition and exercise counselling after auto-SCT: a pilot, randomised controlled trial.

Authors:  Y-C Hung; J D Bauer; P Horsely; J Coll; J Bashford; E A Isenring
Journal:  Bone Marrow Transplant       Date:  2014-04-07       Impact factor: 5.483

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.